Regulation of cancer cell migration and bone metastasis by RANKL.
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Bone metastases are a frequent complication of many cancers that result in severe disease burden and pain. Since the late nineteenth century, it has been thought that the microenvironment of the local host tissue actively participates in the propensity of certain cancers to metastasize to specific organs, and that bone provides an especially fertile 'soil'. In the case of breast cancers, the local chemokine milieu is now emerging as an explanation for why these tumours preferentially metastasize to certain organs. However, as the inhibition of chemokine receptors in vivo only partially blocks metastatic behaviour, other factors must exist that regulate the preferential metastasis of breast cancer cells. Here we show that the cytokine RANKL (receptor activator of NF-kappaB ligand) triggers migration of human epithelial cancer cells and melanoma cells that express the receptor RANK. RANK is expressed on cancer cell lines and breast cancer cells in patients. In a mouse model of melanoma metastasis, in vivo neutralization of RANKL by osteoprotegerin results in complete protection from paralysis and a marked reduction in tumour burden in bones but not in other organs. Our data show that local differentiation factors such as RANKL have an important role in cell migration and the tissue-specific metastatic behaviour of cancer cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MDA-231 cells and other human breast cancer cells have been shown to express RANK (101, 336)”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [336]
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Self-citationInvolvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Self-citationMetastasis to bone: causes, consequences and therapeutic opportunities
Mundy, G. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc867 · Cited by 2,777
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Fata, J. E., Kong, Y.-Y., Li, J., Sasaki, T., Irie-Sasaki, J., Moorehead, R. A., Elliott, R., Scully, S., Voura, E. B., Lacey, D. L., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00103-3 · Cited by 756
Self-citation
Cited by
Items 701–800 of 864
Khan, A. U. (2010) · Griffith Research Online · doi:10.25904/1912/2343 · Cited by 1
Kar, S. (2020) · NDSU Repository (North Dakota State University) · Cited by 1
Dendritic cell-derived osteoclasts and inflammation-induced bone loss; development and regulation
Alnaeeli, M., & Teng, Y.-T. A. (2008) · UR Research (University of Rochester) · Cited by 1
Inferring tumor evolution using computational phylogenetics
Subramanian, A. (2013) · KiltHub Repository · doi:10.1184/r1/6720203
Yeo, S. K. (2012) · ORCA Online Research @Cardiff (Cardiff University)
Osteoimmunology and Cancer - Clinical Implications
Terpos, E., Gkotzamanidou, M. A., Christoulas, D., & Meletios, A. (2011) · InTech eBooks · doi:10.5772/23546
“Recent studies established that RANKL is a chemoattractant that increases migration and invasion of RANK-positive cancer cells (bone tropism) [51, 52].”
BackgroundMesenchymal Stem Cells in Prostate Cancer
Chanda, D., & Ponnazhagan, S. (2013) · Wiley eBooks · doi:10.1002/9781118660423.ch13
Owen, S. (2014) · ORCA Online Research @Cardiff (Cardiff University)
Novel Approaches to Breast Cancer Prevention and Inhibition of Metastases
Penninger, J. M. (2013)
Self-citationTargeting TRAF6 for Cancer Therapeutical Development
Morrow, J. K. (2012) · Digital Commons-TMC (Texas Medical Center)
Warren, J. T. (2015) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7kp809g
Ciblage thérapeutique des tumeurs osseuses primitives par transfert de gène
Lamoureux, F. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
The role of JNK2 and JNK1 in breast cancer mediated invasion and metastasis
Nasrazadani, A. (2010) · Texas ScholarWorks (Texas Digital Library)
Peyruchaud, O. (2010) · IBMS BoneKEy · doi:10.1138/20100447
Spine and scapular pain: an unusual presentation of colon adenocarcinoma
Padhi, P., & Mackey, C. (2013) · BMJ Case Reports · doi:10.1136/bcr-2013-010239
Determinants of Organ-Specific Metastasis
Kang, Y. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511976117.022
RANKing Lung Cancer Bone Metastasis
Peters, S., & Meylan, E. (2012) · Lung Cancer Management · doi:10.2217/lmt.12.16
Introduction to the special issue “The interaction among bone, immunology and vascular biology”
Takayanagi, H., & Morita, I. (2011) · Inflammation and Regeneration · doi:10.2492/inflammregen.31.399
Endocrine manifestations of malignancy
Yousaf, N., & Popat, S. (2017) · Medicine · doi:10.1016/j.mpmed.2017.06.012
Rachner, T. D., & Hofbauer, L. C. (2014) · Springer eBooks · doi:10.1007/978-3-662-43471-0_2
Prevention of bone metatasis in prostate cancer by denosumab: Unneeded endpoint or unmet need?
Ohlmann, C. (2012) · PubMed Central · doi:10.3978/j.issn.2223-4683.2012.05.09
“Transl Androl Urol 2012;1(2):115-117 www.”
BackgroundClément-Demange, L. (2015) · theses.fr (ABES) · doi:10.70675/f8ea456fza28ez4c4ez9d34z17f7e3a82b78
“De nombreuses lignées cellulaires de cancer du sein et de la prostate expriment le récepteur RANK et le traitement par RANKL induit dans ces cellules un remaniement du cytosquelette et une stimulation de la migration in vitro (Jones et al., 2006).”
BackgroundThomas, E. (2012) · UWA Profiles and Research Repository (UWA)
Roles for cathepsin E and RANKL-RANK signaling system in tumor growth and invasion
進, 正. (2009) · Institutional Repositories DataBase (IRDB) · doi:10.15017/14247
Teixeira, M. B. C. G. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2015.tde-07122015-153223
Luciani, A. (2013) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/luciani-andrea_phd2013-02-08
Dissecting the molecular mechanisms of breast cancer bone metastasis for therapeutic targeting
Pollari, S. (2012) · UTUPub (University of Turku)
Zabroda, S. I., Maslyukova, E. A., Li, K., Раскин, Г. А., Pozharissky, K. M., & Корытов, О. В. (2015) · Tumors of female reproductive system · doi:10.17650/1994-4098-2015-11-2-19-24
“Обсуждение Сигнальный путь RANK / RANKL / OPG достаточно изучен в доклинических исследованиях, выработанная гипотеза об участии этих маркеров в образовании метастазов в костной ткани сподвигла ученых к их изучению в естественных условиях [19–21].”
Owen, S., Sanders, A. J., Mason, M. D., & Jiang, W. G. (2016) · PubMed
RANKL inhibition in bone metastases
Wada, T. (2013) · Folia Pharmacologica Japonica · doi:10.1254/fpj.141.22
Self-citationModeling Tumor Initiation as Ricci Flow
Skopec, R. (2016) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.1000279
The Role of the Interleukin-6 Family of Cytokines in Bone Remodeling and Bone Cancer
Blanchard, F., David, E., & Royer, B. B.-L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374895-9.00008-6
Explanation of Metastasis by Homeostatic Inflammation
Maru, Y. (2016) · Springer eBooks · doi:10.1007/978-4-431-56024-1_15
Antibodies for the Treatment of Bone Diseases: Clinical Data
Winzer, M., Rauner, M., & Hofbauer, L. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-34238-2_10
Hormonelle Regulation von WNT1 und SDC1 in humanen Mammakarzinomzellen
Benad, P. (2012) · Qucosa (Saxon State and University Library Dresden)
Paderi, F. (2015) · Padua@research (University of Padova)
Dormant tumor cells in ret transgenic mouse melanoma model and their interaction with memory T cells
Flores-Guzmán, F. (2012) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00013864
Praetorius, L. J. (2009) · e-scholar@UOIT (University of Ontario Institute of Technology)
Demirkaya, O., Al-Qahtani, M. H., Al‐Sugair, A., Aras, Ö., & Abouzied, M. (2017) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000714
Aivazov, M. T., Bozhenko, K. V., Kaprin, А. D., М. Айвазов Т.; ФГУ РНЦРР, М., В. Боженко К.; ФГУ РНЦРР, М., & А. Каприн Д.; ФГУ РНЦРР, М. (2014) · zvestiya of the National Academy of Sciences of Belarus (National Academy of Sciences of Belarus) · doi:10.17650/1726-9776-2010-6-3-57-62
Potential use of Aneustat for improvement of docetaxel-based therapy of advanced prostate cancer
Qu, S. (2017) · cIRcle (University of British Columbia) · doi:10.14288/1.0357970
“RANK, however, is also expressed by prostate cancer cells, and the RANKL produced by osteoblasts shows chemoattractant activity, inducing bone metastasis of RANK-expressing cancer cells [116].”
BackgroundPapp, E. (2014) · TSpace (University of Toronto)
Ma, S. (2018) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/73324
“In cancer biology, the migration capacity of tumor cells plays a vital role in distant metastasis [1, 61].”
BackgroundTargeting bone-microenvironment-tumour cell interactions : IGF-1 receptor kinase inhibitors
Logan, J. G. (2012) · ERA
Pellegrini, P. (2014) · Repositori digital de la UPF (Universitat Pompeu Fabra)
Yang, Y., Li, P., Ding, X.-F., Xi, M. Y., & Guo, X. (2018) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v17i8.5
“Cell migration also plays an essential role in the metastasis of cancer cells [17].”
Design of Peptides to Interfere with the RANK-TRAF6 Pathway: an Integrated Approach
Pereira, M. I. A. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
The role of MSCS in immunoregulation of macrophages during osteogenesis
Huang, R. S. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.123512
Crawford, M. R., Williams, S. E., Khan, L. Z., & Licata, A. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-03694-2_15
Clinical and basic research papers – March 2006 selections
Ferrari, S., Seeman, E., & Strewler, G. J. (2006) · BoneKEy-Osteovision · doi:10.1138/20060204
The role of IKK alpha in prostate cancer bone metastasis
Aljeffery, A. (2019) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Regulation of Breast Cancer Cells’ Bone-Metastatic Potential by Mechanically Stimulated Osteocytes
Ma, Y.-H. V. (2019) · TSpace (University of Toronto)
Endocrine manifestations of malignancy
Balachandran, K., & Popat, S. (2013) · Medicine · doi:10.1016/j.mpmed.2013.07.005
Extraskeletal effects of RANK ligand
Göbel, A., Rachner, T. D., & Hofbauer, L. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00049-x
RECQL4; Linking DNA Replication and Bone Tumourigenesis
Author, U. (2019) · Lincoln Repository (University of Lincoln) · doi:10.24385/lincoln.24326188
Chu, Q. S.-C. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.07.011
Eckardt, J. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8263
OSTEOCYTE SIGNALING AND ITS EFFECTS ON THE ACTIVITES OF OSTEOBLASTS AND BREAST CANCER CELLS
Ahandoust, S. (2021) · Purdue e-Pubs (Purdue University System) · doi:10.25394/pgs.14502360
Effects of NF-κB manipulation on cancer-associated bone disease
Carrasco, G., & Idris, A. I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00040-2
Atrophie, croissance et fonction musculaire : l'impact des leucocytes et de la triade RANK/RANKL/OPG
Dumont, N. A. (2013) · Corpus Université Laval (Université Laval)
Park, M., Cho, Y. J., Kim, B., Ko, Y. J., Jang, Y., Hyun, H., & Lim, W. (2020) · doi:10.21203/rs.3.rs-98591/v1
Involvement of sympathetic nerves in bone metastasis
Elefteriou, F., & Campbell, P. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00065-7
Gómez, R., Tejada, M. A., Rodríguez-García, V. H., Burgués, O., Santos-Llamas, A. I., Martínez‐Massa, A., Marín‐Montes, A., Tarín, J. J., & Cano, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031742
“Early work in breast cancer cell lines already confirmed that both the migratory potential of cells and the potential for bone metastases in mice were strongly influenced by RANKL, which had a promoting effect, and osteoprotegerin (OPG), which behaved as a limiting factor [34].”
BackgroundBen‐Ze'ev, A. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.13453957.14827055
Rucci, N., Ventura, L., & Teti, A. M. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-615-9_7
Premetastatic Microenvironment
Maru, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-1757-7_13
Application of Optical Analyses to Cancer Therapeutics and Diagnostics
Fisher, A. P. (2020) · Cronfa (Swansea University) · doi:10.23889/suthesis.59833
Raman Spectroscopic Investigation of Osteoclastic Activity under the Influence of Bisphosphonate
Marin, E., Adachi, T., Boschetto, F., Zhu, W., Adachi, K., Kanamura, N., Yamamoto, T., & Pezzotti, G. (2022) · Applied Sciences · doi:10.3390/app12083757
“RANKL is considered to be a key signal regulator for cancer-induced bone loss [7].”
BackgroundEpidural metastasis and spinal cord compression
Phillips, K. A., & Schiff, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821976-8.00011-6
Endocrine manifestations of malignancy
Dolly, S. O., & Popat, S. (2009) · Medicine · doi:10.1016/j.mpmed.2009.06.005
Osteoimunologia: uma breve introdução
Souza, J. M. S., & Zerbini, C. A. F. (2012) · Revista Paulista de Reumatologia · doi:10.46833/reumatologiasp.2011.10.s1.30-34
Nakashima, T., & Takayanagi, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_633
Self-citationNakashima, T., & Takayanagi, H. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0461-4_633
Self-citationFormation Mechanism of Bone Metastases
Sağlam, S. (2021) · Turkish Journal of Oncology · doi:10.5505/tjo.2021.s1003
“[15] For example, in lung cancers, RANKL inhibition has also been shown to reduce osteolytic lesions in the bone.”
BackgroundLeibbrandt, A., & Penninger, J. M. (2016) · Springer eBooks · doi:10.1007/978-3-662-46875-3_4945
Self-citationNomura, T., Huang, W., Zhau, H. E., Josson, S., Mimata, H., & Kaur, M. (2014) · ScienceOpen Research · doi:10.14293/a2199-1006.01.sor-astro.xyxyz.v1
Heymann, D., & Heymann, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101718
Heymann, D., & Heymann, M. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101718-1
Leibbrandt, A., & Penninger, J. M. (2015) · Springer eBooks · doi:10.1007/978-3-642-27841-9_4945-2
Self-citation(2011) · Elsevier eBooks · doi:10.1016/b978-0-12-387819-9.00029-3
Hirsh, V. (2014) · Springer eBooks · doi:10.1007/978-3-319-06062-0_15
Regulation of Tumor Progression and Metastasis by Bone Marrow-Derived Microenvironments
Ramchandani, D., Rayes, T. P. E., Gao, D., Altorki, N. K., Cox, T. R., Erler, J. T., & Mittal, V. (2022) · Springer eBooks · doi:10.1007/978-3-030-98950-7_14
Bone Metastasis Of Breast Cancer-A Review
parooei, S. Z. F. (2017) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.997168
Tan, B., Premnath, P., & Venkatakrishnan, K. (2022) · doi:10.32920/21740774.v1
Mouritzen, M. T. (2022) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau515553116
Immune Compartments and Extracellular Matrix Crosstalk Involved in Tumor Dissemination
Malvincini, M., & Alaniz, L. D. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_62-1
Data from Tumor αvβ3 Integrin Is a Therapeutic Target for Breast Cancer Bone Metastases
Zhao, Y., Bachelier, R., Treilleux, I., Pujuguet, P., Peyruchaud, O., Baron, R., Clément-Lacroix, P., & Clézardin, P. (2023) · doi:10.1158/0008-5472.c.6495642
Data from Tumor αvβ3 Integrin Is a Therapeutic Target for Breast Cancer Bone Metastases
Zhao, Y., Bachelier, R., Treilleux, I., Pujuguet, P., Peyruchaud, O., Baron, R., Clément-Lacroix, P., & Clézardin, P. (2023) · doi:10.1158/0008-5472.c.6495642.v1
Discovery of RANKL and the current and future impact of its research
Yasuda, H. (2023) · Folia Pharmacologica Japonica · doi:10.1254/fpj.22127
miRNAs Associated with Bone Metastases in Breast Cancer
蔡, 艳. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1361402
Metadata
- Authors
- Jones, D. H., Nakashima, T., Sanchez, O. H., Kozieradzki, I., Komarova, S. V., Sarosi, I., Morony, S., Rubin, E., Sarao, R., Hojilla, C. V., Komnenovic, V., Kong, Y.-Y., Schreiber, M., Dixon, S. J., Sims, S. M., Khokha, R., Wada, T., & Penninger, J. M.
- Affiliations
- Institute of Molecular Biotechnology (AT)
- University Health Network (CA)
- McGill University (CA)
- Amgen (United States) (US)
- University of Toronto (CA)
- Pohang University of Science and Technology (KR)
- Medical University of Vienna (AT)
- Western University (CA)
- Corresponding author
- Penninger, Josef M.
- ORCID
- Venue
- Nature
- Published
- 2006-03
- Volume
- 440
- Issue
- 7084
- Pages
- 692-696
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2051255001
- Cited by
- 796
- References
- 22
- Citations by year
- 2026: 10 · 2025: 21 · 2024: 24 · 2023: 32 · 2022: 33 · 2021: 43 · 2020: 43 · 2019: 39 · 2018: 28 · 2017: 43 · 2016: 36 · 2015: 42 · 2014: 45 · 2013: 47 · 2012: 68
- FWCI
- 18.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Open Access System for Information Sharing (Pohang University of Science and Technology) (submittedVersion)
- Funders
- European Commission
- Oesterreichische Nationalbank
- Canadian Institutes of Health Research
- National Cancer Institute
- Institute of Musculoskeletal Health and Arthritis
- Canadian Arthritis Network
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- RANKL, RANK, bone metastasis, tumor cell migration, osteoprotegerin, melanoma, breast cancer, tumor microenvironment, NF-κB signaling
- MeSH terms
- Animals, Bone Neoplasms, Breast Neoplasms, Carrier Proteins, Cell Differentiation, Cell Movement, Epithelial Cells, Female, Humans, Melanoma, Membrane Glycoproteins, Neoplasm Metastasis, Organ Specificity, Paralysis, Signal Transduction, Cell Death, Cell Line, Tumor, Cell Proliferation, Mice, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.